<DOC>
	<DOCNO>NCT00000971</DOCNO>
	<brief_summary>To evaluate three dos clarithromycin child AIDS Mycobacterium avium complex ( MAC ) infection receive concurrent antiretroviral therapy . Before extensive evaluation promise drug treatment MAC infection child do , important study pharmacokinetics drug population , get information regard use pediatric patient receive currently available antiretroviral drug , get information antimycobacterial activity drug .</brief_summary>
	<brief_title>The Safety Effectiveness Clarithromycin Plus Zidovudine Dideoxyinosine Treatment Mycobacterium Avium Complex ( MAC ) Infections Children With AIDS</brief_title>
	<detailed_description>Before extensive evaluation promise drug treatment MAC infection child do , important study pharmacokinetics drug population , get information regard use pediatric patient receive currently available antiretroviral drug , get information antimycobacterial activity drug . Patients include HIV infect start zidovudine ( AZT ) didanosine ( ddI ) least 4 week entry study . Patients continue take medication prescribe dos . In addition also take clarithromycin . Patients continue treatment AZT ddI plus clarithromycin 12 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Prophylaxis treatment Pneumocystis carinii pneumonia . Topical antiviral . Prior Medication : Required : Zidovudine ( AZT ) , 90 180 mg/m2 q6h , didanosine ( ddI ) , 60 120 mg/m2 q8h 4 week prior study entry . Patients must follow : Diagnosis AIDS Mycobacterium avium complex . Ability tolerate therapy zidovudine didanosine specify dosage . Written consent parent legal guardian . Willing comply procedure schedule visit . Relatively stable clinical condition . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : History significant depressive disorder . History allergy macrolide antibiotic . Presence acute bacterial infection acute onset opportunistic infection list protocol . Patients follow exclude : Presence current opportunistic infection Mycobacterium avium complex define systemic candidemia , cryptosporidiosis , isosporiasis , toxoplasmosis , pneumocystosis , salmonellosis , acute bacterial infection . Prior Medication : Excluded within 30 day study entry : Systemic antimycobacterial drug , myelosuppressive drug , nephrotoxic agent , cytotoxic experimental chemotherapy , antiviral drug . Active alcohol drug use sufficient opinion investigator prevent adequate compliance medication regimen clinic visit .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 1996</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>